The gene for TNF is polymorphic. Several TNF promoter SNPs have been reported to be associated with disease in humans. DNA sequence variations modifying transcriptional regulation of gene [154] play important role in many complex diseases. The first 200 bp of the

promoter are highly conserved across a range of species, with the murine, bovine and porcine promoters showing approximately 80% homology with the human promoter; while further upstream, there is far less conservation Hydroxychloroquine between species. It has been reported that TNF rs1800630 polymorphism was associated with reduced level of serum TNF-α, because this polymorphism is strongly influence the binding of nuclear proteins [158]. In gene expression, the multiple TFs first assemble at the promoter site and the recruit RNA polymerase. These TFs bind to their cognate binding sites in the promoter region. The presence of polymorphism in regulatory region affects the interaction of TFs with transcription factor–binding site (TFBS), influencing

the expression of gene and thus susceptibility/resistance to disease. We have also predicted several SNPs in the promoter of TNF-alpha, computationally, which lies in TFBS of several TFs in upstream region of TNF-alpha (Table 4). Therefore, we hypothesized that predicted SNPs interfere with gene regulation NVP-BKM120 solubility dmso and will increase the susceptibility to disease. Tumour necrosis factor promoter polymorphism and susceptibility to falciparum malarial infection and pulmonary tuberculosis have been carried out in Indian population. In malaria, TNF-α rs1799964 C and rs1800630 A-alleles as well as homozygotes for the TNF enhancer haplotype CACGG correlated with enhanced plasma TNF levels in both patients and controls. Significantly, higher TNF levels were observed in patients with severe malaria. In tuberculosis, no significant

differences of the allele frequencies between the patients with tuberculosis and controls have been reported but a significant difference in the serum TNF-α level in the patients and the controls has been found. Two TNF polymorphisms rs1800629 and rs361525 show association in most of the diseases (if MTMR9 any association found). Probably, these polymorphisms affect the transcription of gene. Polymorphisms of TNF are likely to contribute to disease, the complex pattern of associations that has been revealed could also be attributable to LD with another susceptibility locus in the vicinity of the gene. By examining LD patterns, we determined that the effect of TNF is independent of the known HLA–A and HLA–DRB1 associations (Fig. 4). The chromosomal region surrounding TNF, however, is abundant in genes of immunologic relevance. To identify true susceptibility genes, the genetic variation of the region must be studied, and extended haplotypes must be constructed and analysed.